Allogeneic Cell Therapy Summit 2020

The 2nd Allogeneic Cell Therapies Summit is the only meeting completely focussed on advancing the development of off-the-shelf therapies by advancing cryopreservation techniques and decreasing cost through industrialized manufacturing.

A network with 250 industry leaders to discuss novel genetic engineering techniques that overcome rejection and avoid GVHD to pave the way for further breakthroughs in patient treatment.

Speakers:

• Jo Brewer VP
• Allogeneic Research Adaptimmune
• Anthony Colenburg Director of Quality Adicet Bio
• Peter Flynn CTO Artiva Biotherapeutics
• Blake Aftab VP, Preclinical and Translational Science Atara Biotherapeutics
• and many more.